Ceramide, a mediator of interleukin 1, tumour necrosis factor α, as well as Fas receptor signalling, induces apoptosis of rheumatoid arthritis synovial cells
Open Access
- 1 August 1998
- journal article
- other
- Published by Elsevier in Annals of the Rheumatic Diseases
- Vol. 57 (8) , 495-499
- https://doi.org/10.1136/ard.57.8.495
Abstract
OBJECTIVES To examine the effects of ceramide, which is a lipid second messenger of cell surface receptors, including tumour necrosis factor α (TNFα), interleukin 1 (IL1), and Fas receptors, on rheumatoid arthritis (RA) synovial cells. METHODS Synovial cells from RA patients and normal skin fibroblasts were cultured with cell permeable ceramide (C2-ceramide). Apoptosis was assessed by microscopic observation of morphological changes, nuclear staining, and DNA electrophoresis. DNA synthesis was examined by thymidine incorporation. RESULTS C2-ceramide induced reversible morphological changes of synovial cells such as cell rounding within four hours. Subsequently, irreversible nuclear changes characteristic to apoptosis were observed at 48 hours. DNA synthesis was not promoted. The addition of ceramide exerted similar effects on cultured dermal fibroblasts. CONCLUSION Ceramide induced apoptosis in RA synovial cells. Ceramide could be a second messenger specific for apoptosis of RA synovial cells.Keywords
This publication has 49 references indexed in Scilit:
- Ceramide induces apoptosis via CPP32 activationFEBS Letters, 1996
- Induction of Fas-dependent apoptosis in synovial infiltrating cells in rheumatoid arthritisInternational Immunology, 1996
- Identification of Actin as a Substrate of ICE and an ICE-like Protease and Involvement of an ICE-like Protease but Not ICE in Vp-16-Induced U937 ApoptosisBiochemical and Biophysical Research Communications, 1995
- Sphingomyelin-ceramide turnover in CD28 costimulatory signalingEuropean Journal of Immunology, 1995
- FAS-induced apoptosis is mediated via a ceramide-initiated RAS signaling pathwayImmunity, 1995
- Inhibition of the production and effects of interleukins‐1 and tumor necrosis factor α in rheumatoid arthritisArthritis & Rheumatism, 1995
- Autoimmune disease. a problem of defective apoptosisArthritis & Rheumatism, 1994
- Activation of the Sphingomyelin Signaling Pathway in Intact EL4 Cells and in a Cell-Free System By IL-1βScience, 1993
- The american rheumatism association 1987 revised criteria for the classification of rheumatoid arthritisArthritis & Rheumatism, 1988
- Recombinant Human Tumor Necrosis Factor-α: Effects on Proliferation of Normal and Transformed Cells in VitroScience, 1985